Thomas N. Burn

Thomas N. Burn

Auto-generated profile, based on publicly available information

Thomas N. Burn

Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MEMaximilien Evrard
Maximilien Evrard
EWErica Wynne-Jones
Erica Wynne-Jones
CPChangwei Peng
Changwei Peng
YKYu Kato
Yu Kato
SCSusan Christo
Susan Christo
LMLaura K. Mackay
Laura K. Mackay
Tissue-resident memory T (TRM) cells provide long-lasting immune protection. One of the key events controlling TRM cell development is the local retention of TRM cell precursors coupled to downregulation of molecules necessary for tissue exit. Sphingosine-1-phosphate receptor 5 (S1PR5) is a migratory receptor with an uncharted function in T cells. Here, we show that S1PR5 plays a critical role in T cell infiltration and emigration from peripheral organs, as well as being specifically downregulated in TRM cells. Consequentially, TRM cell development was selectively impaired upon ectopic expression of S1pr5, whereas loss of S1pr5 enhanced skin TRM cell formation by promoting peripheral T cell sequestration. Importantly, we found that T-bet and ZEB2 were required for S1pr5 induction and that local TGF-β signaling was necessary to promote coordinated Tbx21, Zeb2, and S1pr5 downregulation. Moreover, S1PR5-mediated control of tissue residency was conserved across innate and adaptive immune compartments. Together, these results identify the T-bet–ZEB2–S1PR5 axis as a previously unappreciated mechanism modulating the generation of tissue-resident lymphocytes.

1 December 2023 in Science
Verified
Journal Article
Closed access
SPSimone L. Park
Simone L. Park
SCSusan Christo
Susan Christo
AWAlexandria C. Wells
Alexandria C. Wells
LGLuke C. Gandolfo
Luke C. Gandolfo
AZAli Zaid
Ali Zaid
LMLaura K. Mackay
Laura K. Mackay
Skin-resident CD8+T cells include distinct interferon-γ–producing [tissue-resident memory T type 1 (TRM1)] and interleukin-17 (IL-17)–producing (TRM17) subsets that differentially contribute to immune responses. However, whether these populations use common mechanisms to establish tissue residence is unknown. In this work, we show that TRM1 and TRM17 cells navigate divergent trajectories to acquire tissue residency in the skin. TRM1 cells depend on a T-bet–Hobit–IL-15 axis, whereas TRM17 cells develop independently of these factors. Instead, c-Maf commands a tissue-resident program in TRM17 cells parallel to that induced by Hobit in TRM1 cells, with an ICOS–c-Maf–IL-7 axis pivotal to TRM17 cell commitment. Accordingly, by targeting this pathway, skin TRM17 cells can be ablated without compromising their TRM1 counterparts. Thus, skin-resident T cells rely on distinct molecular circuitries, which can be exploited to strategically modulate local immunity.

30 March 2018 in Hepatology
Verified
Journal Article
Closed access
PDF file
CCCatherine A. Chapin
Catherine A. Chapin
TBThomas Burn
Thomas Burn
TMTomas Meijome
Tomas Meijome
KLKathleen M. Loomes
Kathleen M. Loomes
HMHector Melin‐Aldana
Hector Melin‐Aldana
EAEstella M. Alonso
Estella M. Alonso

31 January 2025 in Science Immunology
Verified
Journal Article
Closed access
CGCatarina Gago da Graça
Catarina Gago da Graça
ASAmania A. Sheikh
Amania A. Sheikh
DNDane M. Newman
Dane M. Newman
LWLifen Wen
Lifen Wen
SLSining Li
Sining Li
DUDaniel T. Utzschneider
Daniel T. Utzschneider
Stem-like T cells are attractive immunotherapeutic targets in patients with cancer given their ability to proliferate and differentiate into effector progeny. Thus, identifying T cells with enhanced stemness and understanding their developmental requirements are of broad clinical and therapeutic interest. Here, we demonstrate that during acute infection, the transcriptional regulator inhibitor of DNA binding 3 (ID3) identifies stem-like T cells that are uniquely adapted to generate precursors of exhausted T (Tpex) cells in response to chronic infection or cancer. Expression of ID3 itself enables Tpex cells to sustain T cell responses in chronic infection or cancer, whereas loss of ID3 results in impaired maintenance of CD8 T cell immunity. Furthermore, we demonstrate that interleukin-1 (IL-1) family members, including IL-36β and IL-18, promote the generation of ID3 + T cells that mediate superior tumor control. Overall, we identify ID3 as a common denominator of stem-like T cells in both acute and chronic infections that is specifically required to sustain T cell responses to chronic stimulation.

9 August 2019 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
TBThomas N. Burn
Thomas N. Burn
LWLehn Weaver
Lehn Weaver
JRJulia E. Rood
Julia E. Rood
NCNiansheng Chu
Niansheng Chu
ABAaron Bodansky
Aaron Bodansky
EBEdward M. Behrens
Edward M. Behrens

29 December 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
TBThomas N. Burn
Thomas N. Burn
JSJan Schröder
Jan Schröder
LGLuke C. Gandolfo
Luke C. Gandolfo
MOMaleika Osman
Maleika Osman
EWElanor N. Wainwright
Elanor N. Wainwright
LMLaura K. Mackay
Laura K. Mackay
CD8 + T cells are an important weapon in the therapeutic armamentarium against cancer. While CD8 + CD103 + T cells with a tissue-resident memory T (T RM ) cell phenotype are associated with favorable prognoses, the tumor microenvironment also contains dysfunctional exhausted T (T EX ) cells that exhibit a variety of T RM -like features. Here we deconvolute T RM and T EX cells across human cancers, ascribing markers and gene signatures that distinguish these populations and enable their functional distinction. Although T RM cells have superior functionality and are associated with long-term survival post-tumor resection, they are not associated with responsiveness to immune checkpoint blockade. Tumor-associated T EX and T RM cells are clonally distinct, with the latter comprising tumor-independent bystanders and tumor-specific cells segregated from cognate antigen. Intratumoral T RM cells can be forced toward an exhausted fate when chronic antigen stimulation occurs, indicating that the presence or absence of continuous antigen exposure within the microenvironment is the key distinction between tumor-associated T EX and T RM populations. These results highlight unique functions for T RM and T EX cells in tumor control, underscoring the need for distinct strategies to harness these populations for cancer therapies.